Suppr超能文献

加拿大衰弱网络峰会会议记录:为加拿大衰弱老年人优化药物治疗,多伦多,2017年4月24日(周一)

Proceedings of the Canadian Frailty Network Summit: Medication Optimization for Frail Older Canadians, Toronto, Monday April 24, 2017.

作者信息

Muscedere John, Kim Perry, Aitken Peter, Gaucher Michael, Osborn Robin, Farrell Barbara, Holroyd-Leduc Jayna, Mallery Laurie, Siu Henry, Downar James, Lee Todd C, McDonald Emily, Burry Lisa

机构信息

Department of Critical Care Medicine, Queen's University, Kingston, ON, Canada.

Canadian Frailty Network, Kingston, ON, Canada.

出版信息

Can Geriatr J. 2017 Dec 22;20(4):253-263. doi: 10.5770/cgj.20.293. eCollection 2017 Dec.

Abstract

Appropriate and optimal use of medication and polypharmacy are especially relevant to the care of older Canadians living with frailty, often impacting their health outcomes and quality of life. A majority (two thirds) of older adults (65 or older) are prescribed five or more drug classes and over one-quarter are prescribed 10 or more drugs. The risk of adverse drug-induced events is even greater for those aged 85 or older where 40% are estimated to take drugs from 10 or more drug classes. The Canadian Frailty Network (CFN), a pan-Canadian non-for-profit organization funded by the Government of Canada through the Networks of Centres of Excellence Program (NCE), is dedicated to improving the care of older Canadian living with frailty and, as part of its mandate, convened a meeting of stakeholders from across Canada to seek their perspectives on appropriate medication prescription. The CFN Medication Optimization Summit identified priorities to help inform the design of future research and knowledge mobilization efforts to facilitate optimal medication prescribing in older adults living with frailty. The priorities were developed and selected through a modified Delphi process commencing before and concluding during the summit. Herein we describe the overall approach/process to the summit, a summary of all the presentations and discussions, and the top ten priorities selected by the participants.

摘要

药物的合理与优化使用以及多重用药问题,对于体弱的加拿大老年人的护理尤为重要,这往往会影响他们的健康状况和生活质量。大多数(三分之二)老年人(65岁及以上)被开具了五种或更多类别的药物,超过四分之一的老年人被开具了十种或更多药物。对于85岁及以上的老年人来说,药物不良反应事件的风险甚至更高,据估计,40%的此类老年人服用的药物来自十种或更多类别。加拿大衰弱网络(CFN)是一个由加拿大政府通过卓越中心网络计划(NCE)资助的泛加拿大非营利组织,致力于改善对体弱的加拿大老年人的护理,作为其任务的一部分,该组织召集了来自加拿大各地的利益相关者会议,以征求他们对合理用药处方的看法。CFN药物优化峰会确定了优先事项,以帮助为未来的研究设计和知识传播工作提供信息,从而促进对体弱老年人的优化用药处方。这些优先事项是通过在峰会前开始并在峰会期间结束的改进德尔菲法制定和选定的。在此,我们描述了峰会的总体方法/过程、所有演讲和讨论的总结,以及参与者选定的十大优先事项。

相似文献

4
Enabling Healthy Aging to AVOID Frailty in Community Dwelling Older Canadians.
Can Geriatr J. 2022 Jun 1;25(2):202-211. doi: 10.5770/cgj.25.536. eCollection 2022 Jun.
6
What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.
PLoS One. 2015 Apr 7;10(4):e0122246. doi: 10.1371/journal.pone.0122246. eCollection 2015.
7
Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education.
J Am Med Dir Assoc. 2021 Jan;22(1):43-49. doi: 10.1016/j.jamda.2020.05.004. Epub 2020 Jul 12.
8
Medication prescribing in frail older people.
Eur J Clin Pharmacol. 2013 Mar;69(3):319-26. doi: 10.1007/s00228-012-1387-2. Epub 2012 Sep 11.
9
Customizing a Program for Older Adults Living with Frailty in Primary Care.
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211034807. doi: 10.1177/21501327211034807.

引用本文的文献

1
Using Comprehensive Geriatric Assessment in Identifying Care Goals and Referral Services in a Frailty Intervention Clinic.
Can Geriatr J. 2023 Dec 1;26(4):530-537. doi: 10.5770/cgj.26.683. eCollection 2023 Dec.
3
Winter Issue, 2017.
Can Geriatr J. 2017 Dec 22;20(4):240. doi: 10.5770/cgj.20.324. eCollection 2017 Dec.

本文引用的文献

1
Pharmacological interventions for the treatment of delirium in critically ill adults.
Cochrane Database Syst Rev. 2019 Sep 3;9(9):CD011749. doi: 10.1002/14651858.CD011749.pub2.
2
Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension.
Hypertension. 2017 Aug;70(2):259-266. doi: 10.1161/HYPERTENSIONAHA.116.09390. Epub 2017 Jun 26.
3
Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study.
J Am Med Dir Assoc. 2017 Jul 1;18(7):624-628. doi: 10.1016/j.jamda.2017.02.009. Epub 2017 Apr 7.
4
Developing and testing an electronic medication administration monitoring device for community dwelling seniors: a feasibility study.
Pilot Feasibility Stud. 2017 Feb 1;3:5. doi: 10.1186/s40814-016-0118-3. eCollection 2017.
5
Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study.
J Am Geriatr Soc. 2017 Feb;65(2):e27-e32. doi: 10.1111/jgs.14718. Epub 2016 Dec 26.
6
Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study.
Am J Kidney Dis. 2017 Feb;69(2):228-236. doi: 10.1053/j.ajkd.2016.08.034. Epub 2016 Nov 22.
7
Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people.
Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):637-46. doi: 10.1002/pds.3772. Epub 2015 Apr 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验